ESR-LOGOS REIT secures 20-year master lease for 3 Tuas South Ave 4

PharmaGend Global Medical Services is the lessee.

ESR-LOGOS REIT (E-LOG)has inked a 20-year master lease with PharmaGend Global Medical Services (PharmaGend) at 3 Tuas South Ave 4.

In a bourse filing, the REIT said the master lease represents a “|contribution of approximately 1.0% of E-LOG’s portfolio rental income as of 30 September 2023.”

The lease also extends E-LOG’s weighted average lease expiry (WALE) from 3.4 years to 3.5 years and represents a positive rental growth of over 35% over the previous lease.

3 Tuas South Ave 4 is a three-storey pharmaceutical manufacturing facility located at the entrance of Tuas Biomedical Park.

The property has a gross floor area of 29,449 sqm and sits on a land area of 59,708 sqm, with an unutilised plot ratio providing an additional c.19,000 sqm of potential gross floor area for future expansion and has a remaining land tenure of 35.3 years.

Follow the link for more news on

ESR-REIT

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia